3D In Vitro Reproductive Models
Mini-testis co-cultures of spermatogonia, Sertoli and Leydig cells in an ECM scaffold. Available for mouse, rat, canine and human.
Explore modelsReprotox Biotech helps drug-development and chemical-safety teams predict male reproductive toxicity using multi-species 3D mini-testis models and testicular organoids (rodent, canine and human), high-content imaging and machine-learning analysis.
NIH SBIR Phase INIEHS R43ES031890
NIH SBIR Phase IINIEHS R44ES027374Our 3D mini-testis model was profiled against 87 reference compounds and benchmarked against traditional in vivo reproductive toxicity data.
Standard assays or a study designed around your compounds, timelines and regulatory questions.
Mini-testis co-cultures of spermatogonia, Sertoli and Leydig cells in an ECM scaffold. Available for mouse, rat, canine and human.
Explore models
Automated high-throughput imaging with multi-parametric, AOP-aligned phenotypic profiling and machine-learning analysis.
See assays
Affordable, scalable study designs for drugs and environmental chemicals, with clear reporting.
Design a studyPrimary canine (dog) Sertoli cells in 1 mL stock vials. Rat Sertoli cells on request. Order →
Cell-specific pathways, DNA damage and cytoskeletal disruption.
Reproductive toxicology assessment and NAM strategy support.
Tell us about your compounds, species of interest and the decision you need to make.
We propose models, endpoints, concentrations and timelines, plus a quote.
Compounds run in 3D mini-testis models with automated high-content imaging.
Quantitative, mechanism-informed results with ML-based hazard prioritization.
Yin L, Hu JC, Xia M, Yu X. Toxicological Sciences. 2025;208(2):279–300.
Recognized for our high-content toxicological profiling of 87 compounds using a 3D mouse mini-testis model.
Read moreNew work on microplastic accumulation in mammalian reproductive tissues, comparing domestic dogs and human samples.
Read moreAwarded by the Technology Research Collaborative Board and the New Mexico Economic Development Department.
Read moreReprotox Biotech LLC is a biotechnology company in the UNM Science & Technology Park in Albuquerque, New Mexico. We develop and validate animal-free New Approach Methodologies (NAMs) for reproductive toxicology: 3D mini-testis models and testicular organoids, high-content imaging assays, machine-learning analysis and primary testicular cells such as canine Sertoli cells.
Our work is supported by NIH SBIR Phase I and Phase II funding from NIEHS and recognized with the NIH Complement-ARIE Challenge Prize and the RDTSS Best Paper in Toxicological Sciences.
Reprotox Biotech (rptox.com) is an independent company and is not affiliated with the REPROTOX® reproductive toxicology database (reprotox.org).
It evaluates whether drugs or chemicals harm reproductive cells and tissues using cell-based models instead of live animals. We focus on male reproductive toxicity, testing compounds on 3D mini-testis models and testicular cells to identify hazards early in drug discovery and chemical safety assessment.
A three-dimensional co-culture of spermatogonia, Sertoli and Leydig cells in an extracellular matrix that mimics the structure and signaling of the testis. Our models are available from mouse, rat and canine sources, including stage-specific testicular organoids.
In a peer-reviewed study of 87 reference compounds, our 3D mini-testis model showed 91.5% sensitivity and 93.8% specificity compared with traditional in vivo reproductive toxicity data (Yin et al., Toxicological Sciences 2025).
Standard assays only measure whether cells die. Our high-content analysis measures 10+ endpoints and 200+ features per cell, detecting DNA damage, cell-cycle and cytoskeletal effects below lethal doses. See the comparison.
Yes. Primary canine (dog) Sertoli cells (catalog CS-SCs) are available in 1 mL stock vials, with over 95% purity by SOX9 and GATA4. View the product or request a quote.
Talk to our toxicologists about models, endpoints and timelines for your compounds.